GDBYF / Goodbody Health turns focus to preventative diagnostics

Goodbody Health Ltd (AQSE:GDBY) said its 2022 results reflect its successful diversification as it added a wider range of diagnostic tests and began t more_horizontal

Goodbody Health has launched its new mobile phlebotomy service to “develop and increase” the reach of phlebotomy testing. Phlebotomy is a procedur more_horizontal

Goodbody Health signed a contract with blood testing company Thriva as it continues to make progress on extending its phlebotomy services. A phlebotom more_horizontal

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its network of UK clinics will start offering multi-cancer screening service, as part of a partnersh more_horizontal

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) has announced that its chair Geremy Thomas will be stepping down from his executive duties, effective 1st more_horizontal

Goodbody Health has agreed to sell its Polish CBD-related operations to Voyager Life for £1.5mln, comprising £0.5m cash and £1mln of convertible lo more_horizontal

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) has announced that George Thomas, an existing executive director of the company and managing director of more_horizontal

Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its focus is now on preventative diagnostics as it looks to become a “leading aggregator” of inn more_horizontal